The inhibition of the mTOR pathway can block this process, providing a basis for combined therapeutic strategies targeting FGF19 and mTOR, offering a new direction for tumor treatment, particularly in targeting tumor metabolism. This evidence concerns the gene MTOR and neoplasm.